A judge has finalized a $190 million settlement between Johns Hopkins Hospital and more than 8,000 patients of a gynecologist who used tiny cameras to secretly photograph women and girls during examinations.
Signaling the seriousness of the threat posed by antibiotic-resistant germs, President Barack Obama has ordered the government to create a national plan to fight them by early 2015.
The Food and Drug Administration on Friday revised sweeping food safety rules proposed last year after farmers complained that the regulations could hurt business. The new proposals would relax water quality standards and allow farmers to harvest crops sooner after using raw manure as fertilizer.
More than 700 infants may have been exposed to tuberculosis at an El Paso hospital over the past year by an employee recently diagnosed with the illness, health officials said Friday.
Silarus Therapeutics and Thyritope Biosciences each will receive up to $10M in Series A financing and R&D support from Avalon Ventures and GSK. Both companies will be located at COI Pharmaceuticals in San Diego, the community of innovation established by Avalon Ventures to provide operational support, a fully equipped R&D facility and an experienced leadership team to its life science portfolio companies.
Auxilium, based in Chesterbrook, Pennsylvania, had adopted a one-year "poison pill" shareholder rights plan last week. The drugmaker continues to support its plan to combine with Canadian eye drugmaker QLT Inc. in an all-stock deal.
Doctors treating a Spanish priest who was repatriated from West Africa on Monday after being diagnosed with the Ebola virus said there were no samples of experimental drug ZMapp available in the world right now, and they were considering alternative treatments.
Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion. Darmstadt-based Merck KGaA said Monday it is paying $140 per share in cash for all of Sigma-Aldrich's shares — a premium of 37 percent over Friday's closing price of $102.37.
CNN's Dr. Sanjay Gupta talks with two leading experts on psychoactive drug research.
Treatment options for advanced breast cancer are desperately needed, according to cancer experts around the world. Also, a new study found that antidepressants may take less time to work than previously thought.
Thousands of health workers began knocking on doors across Sierra Leone on Friday in search of hidden Ebola cases as the entire West African nation was locked down in their homes in an unprecedented effort to combat the deadly disease.
A Baltimore judge was set to hear objections Friday to a preliminary $190 million dollar settlement between Johns Hopkins Hospital System and more than 8,000 patients of a gynecologist who used tiny cameras to secretly photograph women and girls during examinations.
The addition significantly expands PCI's presence in the UK/EU to support global investigational studies of medicinal products by adding packaging, storage and distribution capacity, as well as consultative services for clinical trial supplies.
The objectives of the contract are to advance the development of Soligenix's thermostabilization technology, ThermoVax, combined with the company's ricin toxin vaccine, Rivax, as a medical countermeasure (MCM) to prevent the effects of ricin exposure.
A former executive of drugmaker GlaxoSmithKline and four Chinese co-defendants have been sentenced to prison in a bribery case but may never have to serve that time. China's official Xinhua News Agency said Briton Mark Reilly and his Chinese co-defendants were given a three-year reprieve at their sentencing Friday.